Tissue viability (wound management)

Permanent URI for this collection

Research outputs from the Tissue Viability Service at the RD&E.


Recent Submissions

Now showing 1 - 5 of 6
  • Item
    Evaluating an incontinence cleanser and skin protectant ointment for managing incontinence-associated dermatitis
    (Schofield Publishing, 2017-03) Bradbury, S.; Price, Juliet; Gaffing, J.; Yoro, E.
    Incontinence-associated dermatitis (IAD) relates to skin breakdown from exposure to urine or faeces, and its management involves implementation of structured skin care regimens that incorporate use of appropriate skin barrier products to protect the skin from exposure to moisture and irritants. Medi Derma-Pro Foam & Spray Cleanser and Medi Derma-Pro Skin Protectant Ointment are recent additions to the Total Barrier Protection™ (Medicareplus International) range indicated for management of moderate-to-severe IAD and other moisture-associated skin damage. This article discusses a series of case studies and product evaluations performed to determine clinical outcomes and clinician feedback based on use of the Medi Derma-Pro skin barrier products to manage IAD. Results showed improvements to patients’ skin condition following use of Medi Derma-Pro, and the cleanser and skin protectant ointment were considered better than or the same as the most equivalent products on the market.
  • Item
    Oedema management in a diabetic patient with foot ulceration and peripheral vascular disease: a case study
    (SB Communications Group, 2016) Boulton, Zoe; Price, Juliet
    Peripheral oedema is a recognised complication in prolonging wound healing. Despite this, there is little evidence available on the use of compression therapy in the presence of diabetic foot disease. The case study outlined in this article demonstrates how careful assessment, monitoring and close multidisciplinary working facilitated the use of a reduced compression system to aid wound healing in a diabetic foot.
  • Item
    Facilitating wound bed preparation: properties and clinical efficacy of octenidine and octenidine-based products in modern wound management
    (MAG Online Library, 2016-04-05) Assadian, O.; Hämmerle, G.; Lahnsteiner, E.; Simon, D.; Antunes, J. N. P.; von Hallern, B.; Pilcher, M.; Price, Juliet; Boulton, Zoe; Hunt, S.; Jeffery, S.
    In times when the empiric use of antibiotics is being restricted due to the spread of antimicrobial resistance, the following supplement addresses how topical antiseptics, such as octenidine dihydrochloride (OCT), are less likely to induce resistance. An analysis on how wound cleansers can be used to debride the wound surface without damaging healthy cells is also detailed. This is followed by a series of 18 case studies showing the use of Octenilin Wound Gel and Octenilin Wound Irrigation Solution on non-healing and/or infected or critically colonised non-healing wounds of different wound types including: diabetic foot ulcers, venous leg ulcers and pressure ulcers, among others.
  • Item
    Case 11: large, infected, necrotic mixed-aetiology leg ulcer.
    (MAG Online Library, 2016-03) Price, Juliet; Boulton, Zoe
    This painful and malodorous ulcer was covered with 40% necrotic tissue. Combined use of octenilin Wound gel and Wound Irrigation Solution gently debrided the necrotic tissue, and helped reduce the pain and malodour. Within 6 weeks, the wound was covered with granulation tissue.
  • Item
    Case 12: a neuroischaemic ulcer on the heel.
    (MAG Online Library, 2016-03) Price, Juliet; Boulton, Zoe
    This necrotic ulcer was managed with sharp debridement, octenilin Wound Irrigation Solution and Wound Gel, plus a non-adherent dressing. The significant oedema in the lower limb was controlled with reduced compression. The wound improved steadily over time, healing on week 16.